DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TENIFATECAN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Pancreatic Neoplasms
Unknown
TENIFATECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
7G0Y719Q80
Molecule Type:
Small molecule
Molecular Formula:
C55H72N2O9
Molecular Weight:
905.19
AlogP:
11.38
PSA:
143.25
HBD:
1.0
HBA:
#RotB:
19.0
Source:
RALIMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Glioblastoma; Neoplasms; Ovarian Neoplasms; Breast Neoplasms
MAP kinase p38 alpha inhibitor
RALIMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
73I34XW4HD
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN6
Molecular Weight:
420.54
AlogP:
5.55
PSA:
85.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BMS-394136
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-394136
×
Maximum Phase:
1
First Approval:
None
UNII:
M694U7167K
Molecule Type:
Small molecule
Molecular Formula:
C24H21Cl2FN4O
Molecular Weight:
471.36
AlogP:
5.98
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALOFANIB
1
Small molecule
Investigational
Unknown
Unknown
Stomach Neoplasms
Unknown
ALOFANIB
×
Maximum Phase:
1
First Approval:
None
UNII:
LQX7RFK8MZ
Molecule Type:
Small molecule
Molecular Formula:
C19H15N3O6S
Molecular Weight:
413.41
AlogP:
3.46
PSA:
139.5
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NKTR-171
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel alpha subunit blocker
NKTR-171
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INZOMELID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INZOMELID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H24N4O3S
Molecular Weight:
388.49
AlogP:
2.95
PSA:
93.09
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
RELACATIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RELACATIB
×
Maximum Phase:
1
First Approval:
None
UNII:
BL51M8CB8R
Molecule Type:
Small molecule
Molecular Formula:
C27H32N4O6S
Molecular Weight:
540.64
AlogP:
2.9
PSA:
138.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
RO-4987655
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
RO-4987655
×
Maximum Phase:
1
First Approval:
None
UNII:
I3733P75ML
Molecule Type:
Small molecule
Molecular Formula:
C20H19F3IN3O5
Molecular Weight:
565.29
AlogP:
3.16
PSA:
100.13
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CEP-2563
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurotrophic tyrosine kinase receptor inhibitor
CEP-2563
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBENDAZIM
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Unknown
CARBENDAZIM
×
Maximum Phase:
1
First Approval:
None
UNII:
H75J14AA89
Molecule Type:
Small molecule
Molecular Formula:
C9H9N3O2
Molecular Weight:
191.19
AlogP:
1.74
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BARDOXOLONE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
BARDOXOLONE
×
Maximum Phase:
1
First Approval:
None
UNII:
7HT68L8941
Molecule Type:
Small molecule
Molecular Formula:
C31H41NO4
Molecular Weight:
491.67
AlogP:
6.29
PSA:
95.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MK-7246
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
MK-7246
×
Maximum Phase:
1
First Approval:
None
UNII:
X0LHZ71TLK
Molecule Type:
Small molecule
Molecular Formula:
C21H21FN2O4S
Molecular Weight:
416.47
AlogP:
3.04
PSA:
79.61
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ETACONAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms
Unknown
ETACONAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
3MT15AE9VG
Molecule Type:
Small molecule
Molecular Formula:
C14H15Cl2N3O2
Molecular Weight:
328.2
AlogP:
3.26
PSA:
49.17
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
FOLIGLURAX
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Metabotropic glutamate receptor 4 positive allosteric modulator
FOLIGLURAX
×
Maximum Phase:
1
First Approval:
None
UNII:
FR50CP1D6W
Molecule Type:
Small molecule
Molecular Formula:
C23H23N3O3S
Molecular Weight:
421.52
AlogP:
4.26
PSA:
71.09
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PLUMBAGIN
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
PLUMBAGIN
×
Maximum Phase:
1
First Approval:
None
UNII:
YAS4TBQ4OQ
Molecule Type:
Small molecule
Molecular Formula:
C11H8O3
Molecular Weight:
188.18
AlogP:
1.72
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
AXT914
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AXT914
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
GANTACURIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GANTACURIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
N9VK9ZO25E
Molecule Type:
Small molecule
Molecular Formula:
C53H69ClN2O14+2
Molecular Weight:
993.59
AlogP:
7.84
PSA:
144.9
HBD:
0.0
HBA:
#RotB:
23.0
Source:
CARD-024
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CARD-024
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEDALINAB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
TEDALINAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5R7X34Y6Q1
Molecule Type:
Small molecule
Molecular Formula:
C19H21F2N3O
Molecular Weight:
345.39
AlogP:
4.04
PSA:
46.92
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TAK-243
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAK-243
×
Maximum Phase:
1
First Approval:
None
UNII:
V9GGV0YCDI
Molecule Type:
Small molecule
Molecular Formula:
C19H20F3N5O5S2
Molecular Weight:
519.53
AlogP:
1.75
PSA:
152.07
HBD:
4.0
HBA:
#RotB:
7.0
Source:
SIMMITECAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMMITECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
T4H02O147G
Molecule Type:
Small molecule
Molecular Formula:
C34H38N4O6
Molecular Weight:
598.7
AlogP:
4.26
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
5.0
Source:
NIKKOMYCIN
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
NIKKOMYCIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9Z22C3QQCJ
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O10
Molecular Weight:
495.45
AlogP:
-3.48
PSA:
250.32
HBD:
8.0
HBA:
#RotB:
8.0
Source:
KPT-8602
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KPT-8602
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
82
83
84
85
86
87
88
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA